Skip to main content
. 2017 May 12;17:64. doi: 10.1186/s12886-017-0459-6

Table 1.

Baseline characteristics of patients in Group A (n = 41 eyes) and Group B (n = 36 eyes)

Group A Group B P value
Gender (male: female) 28: 13 27: 9 0.516*
Age (years) 49.2 ± 12.9 47.4 ± 11.6 0.535
  ≤ 50 (number) 21 19 0.891*
  > 50 (number) 20 17
Contralateral eyes with BCVA <20/200 (number) 16 5 0.013*
Disease course (days) 15.0 ± 8.7 11.94 ± 7.2 0.098
Follow-up duration (months) 12.9 ± 4.5 13.6 ± 4.7 0.473
Preoperative logMAR BCVA (Snellen equivalent) 1.22 ± 0.64 (20/332) 1.12 ± 0.58 (20/264) 0.496
Range of RD (clock hours) 4.7 ± 1.5 4.6 ± 1.3 0.707
Macula (on: off) 23: 18 22: 14 0.656*
Superior retinal breaks
 Number 1.9 ± 1.0 2.1 ± 1.0 0.359
 Total area (PD) 2.1 ± 1.0 2.2 ± 1.0 0.646
Lens status (phakic: pseudophakic) 35: 6 31: 5 0.926*
Presence of Inferior retinal breaks (yes: no) 11: 30 10: 26 0.926*

BCVA best corrected visual acuity, logMAR logarithm of minimal angle of resolution, RD retinal detachment, PD papilla diameter

Statistical analysis: * = χ2 analysis;  = unpaired t test;  = unpaired Mann-Whitney test

Continuous values presented as mean ± standard deviation,